slides · global inventory
Resolution
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 42,534
Current window 30,721-30,750
Pages 1,418
Rows per page 30
Beat
30,721-30,750 of 42,534
23
The table uses a red dashed box to highlight the core clinical data rows.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
24
The slide highlights specific safety data points for a competitor product to establish a benchmark.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
25
The slide uses a structured table format to map clinical trial progress against specific disease indications.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
26
The diagram illustrates a dose escalation study design with three cohorts leading to the RP2D.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
27
The slide features a scientific illustration of cellular structures, likely representing the drug delivery mechanism.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
28
Includes scientific diagrams of molecular pathways and comparative efficacy charts.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
29
The slide uses three bar charts to compare IMX-110 performance against benchmarks in mouse models.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
30
Includes a process diagram illustrating the mechanism of action of IMX-110 in tumor microenvironments.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
31
Includes survival curves (Kaplan-Meier), tumor imaging, and tumor frequency metrics.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
32
Immix Biopharma | Investor Presentation Deck | 49 slidesImmix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
33
Includes two side-by-side clinical data visualizations (line charts and bar charts) comparing patient outcomes.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
34
The slide uses a bubble chart to map clinical trial outcomes against patient treatment history and a table to detail specific drug performance metrics.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
35
The chart is a conceptual visualization of 100% of patients achieving 4 months mPFS.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
36
Shows two parallel clinical tracks: monotherapy and combination with tislelizumab.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
11
Innoviz | Results Presentation Deck | 18 slidesInnoviz | Results Presentation Deck | 18 slides · Innoviz
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
12
The slide uses a comparison between current wins and future pipeline to frame the market opportunity.Innoviz | Results Presentation Deck | 18 slides · Innoviz
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
13
Innoviz | Results Presentation Deck | 18 slidesInnoviz | Results Presentation Deck | 18 slides · Innoviz
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
14
The slide explains the revenue decline YoY as a strategic shift in business model (selling components vs full units).Innoviz | Results Presentation Deck | 18 slides · Innoviz
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
15
The slide uses a split-layout design with a dark background and mountain imagery.Innoviz | Results Presentation Deck | 18 slides · Innoviz
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
16
Innoviz | Results Presentation Deck | 18 slidesInnoviz | Results Presentation Deck | 18 slides · Innoviz
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
17
Innoviz | Results Presentation Deck | 18 slidesInnoviz | Results Presentation Deck | 18 slides · Innoviz
Conference presentation Investor relations Beat · Action1 hit
18
Innoviz | Results Presentation Deck | 18 slidesInnoviz | Results Presentation Deck | 18 slides · Innoviz
Conference presentation Investor relations Beat · Action1 hit
59
Kymera | Investor Presentation Deck | 60 slidesKymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · Action1 hit
60
The slide serves as a standard closing/contact slide, featuring a high-impact photo of the company team at Nasdaq.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · Action1 hit
17
Lanvin | Results Presentation Deck | 36 slidesLanvin | Results Presentation Deck | 36 slides · Lanvin Group
Conference presentation Investor relations Beat · Action1 hit
18
Includes a table of key financials (Revenue, Gross Profit, Contribution Profit) for H1 2021-2023.Lanvin | Results Presentation Deck | 36 slides · Lanvin Group
Conference presentation Investor relations Beat · Action1 hit
19
Includes a table of key financials (Revenue, Gross Profit, Contribution Profit) for H1 2021-2023.Lanvin | Results Presentation Deck | 36 slides · Lanvin Group
Conference presentation Investor relations Beat · Action1 hit
20
Includes a footnote regarding non-IFRS financial measures.Lanvin | Results Presentation Deck | 36 slides · Lanvin Group
Conference presentation Investor relations Beat · Action1 hit
21
Includes a table of key financials (Revenue, Gross Profit, Contribution Profit) for H1 21, H1 22, and H1 23.Lanvin | Results Presentation Deck | 36 slides · Lanvin Group
Conference presentation Investor relations Beat · Action1 hit
22
Includes a table of key financials (Revenue, Gross Profit, Contribution Profit) for H1 2021-2023.Lanvin | Results Presentation Deck | 36 slides · Lanvin Group
Conference presentation Investor relations Beat · Action1 hit